POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER Drug Patent Profile
When do Potassium Chloride 20meq In Plastic Container patents expire, and when can generic versions of Potassium Chloride 20meq In Plastic Container launch?
Potassium Chloride 20meq In Plastic Container is a drug marketed by Baxter Hlthcare and Otsuka Icu Medcl and is included in two NDAs.
The generic ingredient in POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER is potassium chloride. There is one drug master file entry for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Potassium Chloride 20meq In Plastic Container
A generic version of POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
- What are the global sales for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
- What is Average Wholesale Price for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER?
Summary for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 308 |
| Patent Applications: | 3,653 |
| DailyMed Link: | POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER at DailyMed |
Pharmacology for POTASSIUM CHLORIDE 20MEQ IN PLASTIC CONTAINER
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |

